RxDoctor Payments Data

Nicholas Pappas

Cardiovascular Disease · Metairie, LANPI 1912079120

Payments from drug & device makers

$2,945in general payments, 2019–2025

Across 221 payments — averaging $13.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$435
  • Pfizer$393
  • Johnson & Johnson$352
  • Sanofi-aventis U.S. LLC$263
  • E.r. Squibb & Sons, L.L.C.$203
  • Amgen$203
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$2,90499%
  • Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,945 in reported general payments places this provider in the 45th percentile of 281 cardiovascular disease providers in Louisiana.

See all cardiovascular disease providers in Louisiana

Other cardiovascular disease in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →